Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients

被引:26
作者
Rezaeepoor, Mahsa [1 ]
Shapoori, Shima [1 ]
Ganjalikhani-hakemi, Mazdak [1 ]
Etemadifar, Masoud [2 ]
Alsahebfosoul, Fereshteh [1 ]
Eskandari, Nahid [1 ]
Mansourian, Marjan [3 ]
机构
[1] Isfahan Univ Med Sci, Fac Med, Dept Immunol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Multiple Sclerosis & Neuroimmunol Res Ctr, Esfahan, Iran
[3] Isfahan Univ Med Sci, Fac Med, Dept Biostat & Epidemiol, Esfahan, Iran
关键词
Semaphorin; 3A; Multiple sclerosis; Autoimmune disease; Immune modulator; SEMAPHORIN; 3A; DISEASE-ACTIVITY; AUTOIMMUNITY; INFLAMMATION; RECEPTORS; ARTHRITIS; CELLS; 7A;
D O I
10.1016/j.gene.2017.02.013
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Semaphorin 3A (Sema3A) as an immune modulator could participate in the pathogenesis of autoimmune diseases. In the current study, we aimed to investigate Sema3A expression in peripheral blood mononuclear cells (PBMCs) and its serum level in relapsing-remitting multiple sclerosis (RRMS) patients. Fifteen newly determined and untreated RRMS patients were chosen and assessed in relapsing and remitting phases in compare with fifteen healthy individuals. In consistent with previous findings in other autoimmune diseases, our results revealed that serum level of Sema3A and its expression in PBMCs of RRMS patients were significantly lower than in normal subjects. We also evaluated this down regulation predictive value with ROC analysis. According to our data, we suggest that Sema3A could be involved in pathogenesis of MS and might be a potential diagnostic biomarker for the disease. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 26 条
[1]  
Bolanos-Jimenez R., 2011, JNBH, V3, P44
[2]   The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis [J].
Catalano, Alfonso .
JOURNAL OF IMMUNOLOGY, 2010, 185 (10) :6373-6383
[3]   Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions [J].
Costa, C. ;
Martinez-Saez, E. ;
Gutierrez-Franco, A. ;
Eixarch, H. ;
Castro, Z. ;
Ortega-Aznar, A. ;
Ramon y Cajal, S. ;
Montalban, X. ;
Espejo, C. .
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (13) :1632-1643
[4]   Immunopathology of multiple sclerosis [J].
Dendrou, Calliope A. ;
Fugger, Lars ;
Friese, Manuel A. .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (09) :545-558
[5]   Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis [J].
Eixarch, Herena ;
Gutierrez-Franco, Ana ;
Montalban, Xavier ;
Espejo, Carmen .
TRENDS IN MOLECULAR MEDICINE, 2013, 19 (03) :157-164
[6]  
Goldenberg Marvin M, 2012, P T, V37, P175
[7]   Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design [J].
Gutierrez-Franco, Ana ;
Costa, Carme ;
Eixarch, Herena ;
Castillo, Mireia ;
Medina-Rodriguez, Eva M. ;
Bribian, Ana ;
de Castro, Fernando ;
Montalban, Xavier ;
Espejo, Carmen .
CLINICAL IMMUNOLOGY, 2016, 163 :22-33
[8]   Decreased Expression of Semaphorin-3A, a Neurite-collapsing Factor, is Associated With Itch in Psoriatic Skin [J].
Kou, Kenzen ;
Nakamura, Fumio ;
Aihara, Michiko ;
Chen, Huichin ;
Seto, Katsuya ;
Komuri-Yamaguchi, Junko ;
Kambara, Takeshi ;
Nagashima, Yoji ;
Goshima, Yoshio ;
Ikezawa, Zenro .
ACTA DERMATO-VENEREOLOGICA, 2012, 92 (05) :521-528
[9]  
Kumanogoh A, 2015, SEMAPHORINS, P137, DOI [10.1007/978-4-431-54385-5_7, DOI 10.1007/978-4-431-54385-5_7]
[10]   A novel role for Sema3A in neuroprotection from injury mediated by activated microglia [J].
Majed, HH ;
Chandran, S ;
Niclou, SP ;
Nicholas, RS ;
Wilkins, A ;
Wing, MG ;
Rhodes, KE ;
Spillantini, MG ;
Compston, A .
JOURNAL OF NEUROSCIENCE, 2006, 26 (06) :1730-1738